Secondary Percutaneous Revascularization for Severe Unprotected Left Main Disease After Surgical Turndown by Triantafyllou, Konstantinos et al.
29 
 
CASE REPORT
Secondary Percutaneous Revascularization for Severe 
Unprotected Left Main Disease After Surgical 
Turndown 
Konstantinos Triantafyllou, MD, Catherine Liontou, MD, 
Serafeim Liapis, MD, Eleni Margioula, MD, Dimitrios 
Stalikas, MD, Nikolaos Sakellaris, MD, Kostas Kappos, MD
Department of Cardiology, Evagelismos Hsospital, Athens, 
Greece; e-mail: kontriad@gmail.com
Conflict of interest: none declared
Abstract
Patients with severe left main and/or multi-vessel coronary 
artery disease (CAD) and contraindications or extremely high 
risk for surgical revascularization that are subsequently referred 
for percutaneous coronary intervention (PCI) have been 
increasing in clinical practice. We present the case of a patient 
with a previous history of aortic valve replacement and coronary 
artery bypass grafting (CABG) hospitalized because of angina 
recurrence and a functional test with myocardial scintigraphy 
that showed extensive myocardial ischemia. The coronary 
angiogram revealed severe left main and two-vessel disease with 
totally occluded bypass grafts, while revascularization by re-do
CABG was rejected. The patient was finally treated by a 
technically challenging high-risk unprotected left main PCI.
Rhythmos 2017;12(2):29-32.
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= percutaneous coronary intervention
Introduction
Over the last several years patients with severe left 
main and/or multi-vessel coronary artery disease (CAD) 
treated with percutaneous coronary interventions (PCI) 
instead of coronary artery bypass grafting (CABG) have 
been increasing in numbers. This is due to the fact that the 
average age and comorbidities burden of patients referred 
for revascularization has been increasing and thus 
scenarios of patients with advanced CAD referred for 
complex PCI after surgical turndown may be frequently 
encountered by the Heart Team. Among them a special 
category are patients with previous CABG that are referred 
for secondary revascularization with PCI.1 Meanwhile the 
improvement of techniques, adjunctive technologies and 
pharmacotherapy have made complex PCI a mostly 
reproducible, effective and safe treatment with acceptably 
low complications rate.2
We herein present the case of a patient with a previous 
history of aortic valve replacement and CABG admitted
because of debilitating angina recurrence attributed to 
severe left main and two-vessel disease along with totally 
occluded bypass grafts. After an unsurprising surgical 
turndown during the Heart Team meeting the patient was 
finally treated with PCI. 
Case presentation
A 64-year-old patient was admitted to our department 
for unstable angina immediately after a strongly positive 
stress test coupled with myocardial scintigraphy imaging 
which showed extensive antero-lateral ischemia. He had a 
history of a severely stenotic bicuspid aortic valve 
replacement with a mechanical one (St Jude 25 mm) and 
also CABG with two saphenous vein grafts to the LAD and 
marginal branch both performed 20 years ago. His risk 
factor profile consisted of active smoking, arterial 
hypertension and dyslipidemia. Furthermore, he had a 
history of non-Hodgkin lymphoma treated with 
chemotherapy and chest radiotherapy 19 years earlier. His 
actual treatment consisted of aspirin 100 mg/d, 
acenocoumarol with target INR around 2.5-3.0, an ACE 
LQKLELWRU Dȕ-blocker and a statin. Concerning his initial 
diagnostic workup, all parameters of his initial blood tests 
were within normal limits, his INR was 2.4 and 
echocardiography revealed a preserved ejection fraction 
without segmental left ventricular wall motion 
abnormalities and a well-functioning mechanical bileaflet 
aortic valve without any other abnormal findings. 
Figure 1. Diagnostic coronary angiography (right radial approach) A. 
LAO cranial view: Severe diffuse disease of the left main (which 
trifurcates distally) is demonstrated. B. LAO caudal view: The diffusely 
and severely narrowed left main is shown. It trifurcates into an LAD
with a chronic total occlusion at its mid segment after supplying a 
significant 1st diagonal branch, a moderately sized ramus intermedius 
and a circumflex artery with a chronic total occlusion of a moderately 
sized marginal branch. C. A dominant right coronary artery without 
significant disease. D. At the end of the right coronary artery contrast 
injection, retrograde late filling is noted of the distal LAD which is 
diffusely diseased and filiform.
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Coronary angiography was performed the day 
following admission from the right radial approach and 
revealed very severe diffuse left main disease (80-90% 
stenosis, with pressure damping when the diagnostic 
catheter touched the ostium), chronic total occlusion of the 
LAD after the origin of a very significant first diagonal 
branch, moderate stenosis of a moderately sized ramus 
intermedius, chronic total occlusion of a moderately sized 
marginal branch and a dominant right coronary artery 
without any stenosis that provided retrograde filling to a 
diffusely infiltrated and filiform distal part of the LAD 
(Fig. 1). The two saphenous vein grafts were occluded, 
while the left internal mammary artery had not been used 
during the initial CABG operation because of poor quality. 
At the Heart Team meeting the option of re-do CABG was 
promptly rejected due to the previous sternotomy and chest 
radiotherapy, while the distal LAD was considered 
unsuitable for grafting. Therefore, percutaneous 
revascularization with a high risk unprotected left main 
PCI procedure was decided.
Figure 2. Procedural steps of unprotected left main PCI (right 
femoral approach). A. A JL4 guiding catheter was positioned 
just in front of the severely stenotic ostium of the left main to 
avoid pressure damping. ȉwo guidewires were cautiously 
advanced distally into the large 1st diagonal and the circumflex 
artery. The positioning of the first 2.5x15mm non-compliant 
balloon in the left main can be seen and it can be appreciated that 
it was partially occlusive for the left coronary system. It was 
inflated at 16 Atm for 10 sec in order to start lesion preparation 
for stenting. B. Two subsequent pre-dilatations of the quite 
resistant left main lesion followed. Initially with a 3x15mm 
scoring balloon at 14 Atm for 10 seconds (Angiosculpt, 
Angioscore) and finally with a 3.5x15mm non-compliant 
balloon at 20 Atm for 10 seconds. C. Positioning of a 3.5x18mm 
biodegradable polymer drug-eluting stent (Orsiro, Biotronik) in 
order to cover the left main from the ostium at its distal part. To 
secure accurate positioning of the stent an Ostial pro device 
(Merit Medical) was used. At the LAO cranial view two of its 
four nitinol legs (black arrows) just outside the guiding catheter 
tip form a line that shows the plane of the left main ostium. This 
was the target to deploy the proximal stent edge in order not to 
miss the left main ostium. D. The stent deployment is shown (at 
16 Atm for 10 sec) and the two of the four Ostial pro legs that 
are 180º apart and form a line at the level of the left main ostium 
can be appreciated (black arrows). The left main stent was finally 
post-dilated with a 4x15mm non-compliant balloon at 20 Atm
for 10 seconds (not shown).
The intervention was performed from the right femoral 
approach and a JL4 guiding catheter was positioned 
initially just in front of the severely narrowed left main 
ostium to avoid pressure damping. Two guidewires were 
advanced distally into the large 1st diagonal branch and the 
circumflex artery. The severe diffuse left main lesion was 
resistant and thus had to be pre-dilated sequentially with a 
2.5x15mm non-compliant balloon, a 3x15mm scoring 
balloon and a 3.5x15mm non-compliant balloon at high 
pressure (up to 20 Atm) (Figure 2, A and B). After 
verifying that the lesion was adequately prepared it was 
decided to implant a 3.5x18mm drug-eluting stent with 
biodegradable polymer (Orsiro, Biotronik) which would 
suffice to cover the ostium and the entire length of the left 
main, according to measurements made with the 15mm 
long balloons used for pre-dilatation. In order to maximize 
implantation precision and avoid interfering with the distal 
left main trifurcation (no ostial disease of the left anterior 
descending, the ramus intermedius or the circumflex was 
noted) we decided to use a device specifically designed for 
accurate placement of stents to treat aorto-ostial lesions 
(Ostial Pro, Merit Medical).3 This is a relatively simple 
device that is positioned within the guiding catheter and 
has four distal, self-expanding nitinol legs that are 
advanced just distal to the tip of the guiding catheter after 
the ostial lesion has been crossed with the coronary 
guidewire and stent. The expanded legs prevent the entry 
of the guiding catheter into the target vessel, mark the 
plane of the aortic wall, and align the tip of the guiding 
catheter with the aorto-ostial plane.4 Thus the proximal 
edge of the stent was positioned exactly at the left main 
ostium which was not missed, while the total length of the 
left main was stented without extending distally into its
trifurcation (Fig. 2, C and D). The stent was inflated at 16 
Atm for 10 seconds and post-dilated with a 4x15mm non-
compliant balloon at 20 Atm for 10 seconds. The final 
angiographic result was optimal (Fig. 3).
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Figure 3. Optimal final angiographic result. A. LAO cranial
view, B. LAO caudal view.
The patient became symptom free and was discharged
48 hours later in good functional status and without 
complications. Triple therapy with aspirin 100 mg/d, 
clopidogrel 75mg/d and acenocumarol with target INR 2.5 
was continued for 3 months and clopidogrel was stopped 
thereafter. Otherwise the patient continued to be treated 
ZLWK RSWLPDOPHGLFDO WKHUDS\ $&( LQKLELWRU ȕ-blocker 
and high-dose statin). A stress test coupled with 
myocardial scintigraphy 6 months later showed no 
myocardial ischemia. The patient remains without
symptoms and in good functional status 2 years after the 
procedure.
Discussion
We described the case example of a patient operated 20 
years ago for aortic valve replacement and CABG with 
angina recurrence due to severe diffuse left main disease 
and occluded saphenous vein grafts.  Being a poor 
candidate for a second surgical revascularization for the 
reasons mentioned above he had to be submitted to a 
secondary revascularization procedure which was a 
technically challenging unprotected left main PCI. 
The possibility that any given patient with CAD will 
require more than one coronary interventions has 
significantly increased during the last two decades. The 
ageing of the population increases the absolute number of 
patients with CAD but also the possibility of disease 
progression or surgical graft failure among those with 
previous CABG. The age of the initial revascularization 
procedure is a significant factor thus younger patients are 
more likely than older ones to have to undergo repeat 
interventions.5 Patients demanding secondary 
revascularization are also more likely to present more 
severe CAD as a result of the time elapsed since the initial 
revascularization procedure, leaving fewer options and 
augmenting the complexity of further re-interventions.1
There has been a shift in practice regarding the modality of 
revascularization in patients with previous CABG during 
the last decades. Re-do CABG was dominant throughout 
the eighties, it was subsequently followed by more 
conservative approaches with decrease of surgical re-
interventions and was finally superseded by crossed 
revascularization with PCI.1,6 Currently only 3% of 
patients with prior CABG undergo re-do CABG.7 Our 
patient was treated according to the 2014 ESC 
revascularization guidelines which in patients with 
previous CABG  recommend PCI as the first choice for 
repeat revascularization if technically feasible rather than 
re-do CABG (class IIa, level of evidence C).2
Technical improvements and the development of drug-
eluting stents led to greater use of PCI for unprotected left 
main disease and to multiple comparisons between the two 
competing revascularization modalities (i.e., PCI with 
drug-eluting stents versus CABG) in randomized trials as 
well as in large registry studies. 8 According to the 
SYNTAX trial results both provided similar results with 
respect to the composite end-point of death, myocardial 
infarction, stroke, or unplanned ischemia-driven 
revascularization. Stroke occurred more frequently in the
CABG group than in the PCI group, whereas the need for 
repeat revascularization was greater in the PCI group than 
in the CABG group.9 As a consequence, PCI with drug-
eluting stents is being used with increasing frequency, 
currently exceeding the frequency of CABG in several 
centers.10,11 In the 2014 ESC revascularization guidelines 
left main PCI holds a class I (level of evidence B) 
UHFRPPHQGDWLRQZKHQ6<17$;VFRUHLVa class IIa 
(level of evidence B) recommendation when SYNTAX 
score is 22-32  and is not recommended when SYNTAX 
score is >32 (class III, level of evidence B).2 The recently 
published EXCEL study further supports left main PCI 
since it has demonstrated that in patients with left main 
GLVHDVHDQG6<17$;VFRUHV3&,ZLWKHYHUROLPXV-
eluting stents was non-inferior to CABG with respect to 
the rate of the composite end point of death, stroke, or 
myocardial infarction at 3 years.12
In our patient, unprotected left main PCI was the only 
option for revascularization, while the diffuse severe 
disease from the ostium until the end of a trifurcating left 
main stem rendered the intervention technically 
challenging. To overcome the difficulties, it was decided 
to use tools that are representative of recent advances in 
percutaneous intervention techniques. Firstly, a scoring 
balloon was used among others to sufficiently prepare a 
chronic, quite resistant, fibrotic left main lesion before 
stenting.13 Secondly, according to recent guidelines the 
lesion was treated with a last generation biodegradable 
polymer drug-eluting stent that allows to keep minimal the 
duration of dual antiplatelet therapy for a patient with a 
mechanical valve and thus obligatory permanent 
anticoagulation treatment.2 Finally, in order to cover the 
entire left main length from the ostium at its distal end with 
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a well sized stent without interfering with its trifurcation 
(and thus adding further complexity to the PCI procedure) 
a device that maximizes accuracy of stent placement to 
treat aorto-ostial lesions was used.4 Therefore the 
presented case can be considered as an example of how 
continuous progress regarding PCI tools and techniques 
contributes to safer interventions, procedural success and 
positive clinical outcomes even in complex cases.
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